pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
789
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
IDOV-Immune
Solid Tumor
Viromissile Inc
0
catalysts
Phase 1
IKS-03
B-Cell Non-Hodgkin Lymphoma
Iksuda Therapeutics Ltd
0
catalysts
Phase 1
IM-1021
Diffuse Large B-Cell Lymphoma
$IMNM
Immunome Inc.
0
catalysts
Phase 1
← prev
page 12 of 27
next →
131
Pain
89
Neurology
1
IM-3050
Solid Tumor
$IMNM
Immunome Inc.
0
catalysts
Phase 1
IMC-002
Solid Tumor
ImmuneOncia Therapeutics Inc
0
catalysts
Phase 1
IN-001
Herpes Zoster (Shingles)
Innorna Co Ltd
0
catalysts
Phase 1
INB-100
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$INAB
IN8BIO, INC.
0
catalysts
Phase 1
INB-200
Glioblastoma Multiforme (GBM)
$INAB
IN8BIO, INC.
0
catalysts
Phase 1
INCA-033989
Essential Thrombocythemia
$INCY
INCYTE CORP
0
catalysts
Phase 1
INCB-100658
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
$INCY
INCYTE CORP
0
catalysts
Phase 1
INO-8000
Hepatitis C
$INO
INOVIO PHARMACEUTICALS, INC.
0
catalysts
Phase 1
INS-1201
Duchenne Muscular Dystrophy
$INSM
INSMED Inc
0
catalysts
Phase 1
INS-1202
Amyotrophic Lateral Sclerosis
$INSM
INSMED Inc
0
catalysts
Phase 1
INT-301
Peanut Allergy
Intrommune Therapeutics Inc
0
catalysts
Phase 1
INV-101
Ulcerative Colitis
Innovo Therapeutics Co Ltd
0
catalysts
Phase 1
INVA-8001
Atopic Dermatitis (Atopic Eczema)
Invea Therapeutics Inc
0
catalysts
Phase 1
IO-202
Chronic Myelomonocytic Leukemia (CMML)
Immune Onc Therapeutics Inc
0
catalysts
Phase 1
IPH-4502
Breast Cancer
$IPHA
Innate Pharma SA
0
catalysts
Phase 1
ISB-2001
Refractory Multiple Myeloma
$ABBV
AbbVie Inc.
0
catalysts
Phase 1
ISM-3412
Solid Tumor
InSilico Medicine
0
catalysts
Phase 1
ISM-6331
Malignant Mesothelioma
InSilico Medicine
0
catalysts
Phase 1
ITI-1001
Glioblastoma Multiforme (GBM)
Immunomic Therapeutics Inc
0
catalysts
Phase 1
ITI-3000
Merkel Cell Carcinoma
Immunomic Therapeutics Inc
0
catalysts
Phase 1
IVB-003
Pancreatic Cancer
Invictus Therapeutics Ltd
0
catalysts
Phase 1
IVMED-85
Myopia
iVeena Delivery Systems Inc
0
catalysts
Phase 1
Improved TNS9
Thalagen
Beta Thalassaemia
San Rocco Therapeutics LLC
0
catalysts
Phase 1
Innocell Vaccine
Epithelial Ovarian Cancer
PhotonPharma Inc
0
catalysts
Phase 1
JANX-007
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JANX
Janux Therapeutics, Inc.
0
catalysts
Phase 1
JANX-008
Head And Neck Squamous Cell Carcinoma (HNSC)
$JANX
Janux Therapeutics, Inc.
0
catalysts
Phase 1
JBZ-001
Diffuse Large B-Cell Lymphoma
Jabez Biosciences Inc
0
catalysts
